Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-20

Clinical Trial Update: Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery [Phase 1]

View source ↗

Summary

Phase 1 study update evaluating whether triiodothyronine (T3) affects the incidence of atrial fibrillation in patients undergoing cardiac surgery; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triiodothyronine (T3) (triiodothyronine)

Snippet

Sponsor: Northwell Health | Conditions: Atrial Fibrillation | Phase 1 | Status: COMPLETED